成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 934-98-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 934-98-5
Chemical Structure| 934-98-5
Structure of 934-98-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 934-98-5 ]

Related Doc. of [ 934-98-5 ]

Alternatived Products of [ 934-98-5 ]
Product Citations

Product Citations

Li, Bowen ; Manan, Rajith Singh ; Liang, Shun-Qing , et al. DOI: PubMed ID:

Abstract: The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for mRNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 934-98-5 ]

CAS No. :934-98-5 MDL No. :MFCD03701701
Formula : C7H17N3 Boiling Point : No data available
Linear Structure Formula :- InChI Key :GOWUDHPKGOIDIX-UHFFFAOYSA-N
M.W : 143.23 Pubchem ID :70284
Synonyms :

Calculated chemistry of [ 934-98-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.98
TPSA : 32.5 ?2

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.79 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : -0.87
Log Po/w (WLOGP) : -1.57
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : -0.2
Consensus Log Po/w : -0.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.05
Solubility : 128.0 mg/ml ; 0.896 mol/l
Class : Very soluble
Log S (Ali) : 0.67
Solubility : 669.0 mg/ml ; 4.67 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.47
Solubility : 48.0 mg/ml ; 0.335 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 934-98-5 ]

Signal Word:Danger Class:8
Precautionary Statements:P264-P270-P271-P272-P280-P305+P351+P338-P310-P330-P331-P303+P361+P353-P304+P340-P363-P403+P233-P501 UN#:2735
Hazard Statements:H314-H317-H302+H312 Packing Group:Ⅲ
GHS Pictogram:

Application In Synthesis of [ 934-98-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 934-98-5 ]

[ 934-98-5 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 934-98-5 ]
  • [ 27018-76-4 ]
  • 1-benzyl-1<i>H</i>-indole-3-carboxylic acid [2-(4-methyl-piperazin-1-yl)-ethyl]-amide [ No CAS ]
  • 2
  • [ 934-98-5 ]
  • [ 120085-99-6 ]
  • 2,9-bis{4-[(2-(4-methylpiperazin-1-yl)ethyl)iminomethyl]phenyl}-1,10-phenanthroline [ No CAS ]
  • 3
  • [ 934-98-5 ]
  • [ 97-08-5 ]
  • 4-chloro-N-(2-(4-methylpiperazin-1-yl)ethyl)-3-nitrobenzenesulfonamide [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 934-98-5 ]

Amines

Chemical Structure| 142-25-6

[ 142-25-6 ]

N1,N1,N2-Trimethylethane-1,2-diamine

Similarity: 0.85

Chemical Structure| 326888-32-8

[ 326888-32-8 ]

N1,N1,N2-Trimethylethane-1,2-diamine dihydrochloride

Similarity: 0.79

Chemical Structure| 34885-02-4

[ 34885-02-4 ]

3-(Piperazin-1-yl)propan-1-amine

Similarity: 0.76

Chemical Structure| 636-70-4

[ 636-70-4 ]

Triethylamine hydrobromide

Similarity: 0.71

Chemical Structure| 7154-73-6

[ 7154-73-6 ]

Pyrrolidinoethylamine

Similarity: 0.63

Related Parent Nucleus of
[ 934-98-5 ]

Aliphatic Heterocycles

Chemical Structure| 34885-02-4

[ 34885-02-4 ]

3-(Piperazin-1-yl)propan-1-amine

Similarity: 0.76

Chemical Structure| 5845-28-3

[ 5845-28-3 ]

1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide

Similarity: 0.72

Chemical Structure| 122-96-3

[ 122-96-3 ]

2,2'-(Piperazine-1,4-diyl)diethanol

Similarity: 0.72

Chemical Structure| 38216-72-7

[ 38216-72-7 ]

1-tert-Butylpiperazine

Similarity: 0.72

Chemical Structure| 126055-32-1

[ 126055-32-1 ]

1-(2-Chloroethyl)-4-methylpiperazine hydrochloride

Similarity: 0.72

Piperazines

Chemical Structure| 109-01-3

[ 109-01-3 ]

1-Methylpiperazine

Similarity: 1.00

Chemical Structure| 4318-42-7

[ 4318-42-7 ]

1-Isopropylpiperazine

Similarity: 0.81

Chemical Structure| 142-64-3

[ 142-64-3 ]

Piperazine Dihydrochloride

Similarity: 0.79

Chemical Structure| 34885-02-4

[ 34885-02-4 ]

3-(Piperazin-1-yl)propan-1-amine

Similarity: 0.76

Chemical Structure| 5845-28-3

[ 5845-28-3 ]

1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide

Similarity: 0.72

; ;